CrossRef High-fat diet, gut dysbiosis, and oxidative stress: A synergistic triangle in metabolic dysfunction-associated steatotic liver disease pathogenesis Zi-Rui Zhang, Ling She, Yi-Rong Cao, Yuan-Wen Chen World Journal of Hepatology .2026;[Epub] CrossRef Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver disease Allen Anthony Larao, Silvia Palmisano, Deborah Bonazza, Discipio Marina, Marica Meroni, Anna Ludovica Fracanzani, Lory S Croc, Claudio Tiribelli, Paola Dongiovanni, Natalia Rosso, Pablo Giraudi Annals of Hepatology .2026
The evolving therapeutic landscape demands we weigh metformins benefits against newer agents that offer more than glucose control alone
Food and Drug Administration approved the selective thyroid hormone receptor -agonist, resmetirom, in the USA for the treatment of non-cirrhotic MASH with moderate-to-advanced fibrosis
Our online medical weight loss program in Atlanta provides real clinical supportnot just prescriptions
How long does it take for a Vitamin B12 injection to work
